全文获取类型
收费全文 | 18902篇 |
免费 | 1500篇 |
国内免费 | 509篇 |
专业分类
耳鼻咽喉 | 81篇 |
儿科学 | 254篇 |
妇产科学 | 217篇 |
基础医学 | 1455篇 |
口腔科学 | 222篇 |
临床医学 | 1471篇 |
内科学 | 4238篇 |
皮肤病学 | 358篇 |
神经病学 | 1062篇 |
特种医学 | 153篇 |
外国民族医学 | 1篇 |
外科学 | 1926篇 |
综合类 | 1034篇 |
现状与发展 | 2篇 |
预防医学 | 385篇 |
眼科学 | 215篇 |
药学 | 4911篇 |
5篇 | |
中国医学 | 375篇 |
肿瘤学 | 2546篇 |
出版年
2024年 | 29篇 |
2023年 | 449篇 |
2022年 | 522篇 |
2021年 | 916篇 |
2020年 | 858篇 |
2019年 | 894篇 |
2018年 | 880篇 |
2017年 | 855篇 |
2016年 | 728篇 |
2015年 | 801篇 |
2014年 | 1048篇 |
2013年 | 2217篇 |
2012年 | 888篇 |
2011年 | 1051篇 |
2010年 | 759篇 |
2009年 | 791篇 |
2008年 | 869篇 |
2007年 | 742篇 |
2006年 | 733篇 |
2005年 | 573篇 |
2004年 | 489篇 |
2003年 | 430篇 |
2002年 | 397篇 |
2001年 | 331篇 |
2000年 | 264篇 |
1999年 | 227篇 |
1998年 | 240篇 |
1997年 | 200篇 |
1996年 | 183篇 |
1995年 | 167篇 |
1994年 | 136篇 |
1993年 | 130篇 |
1992年 | 121篇 |
1991年 | 99篇 |
1990年 | 91篇 |
1989年 | 89篇 |
1988年 | 68篇 |
1987年 | 77篇 |
1986年 | 54篇 |
1985年 | 82篇 |
1984年 | 75篇 |
1983年 | 46篇 |
1982年 | 61篇 |
1981年 | 43篇 |
1980年 | 41篇 |
1979年 | 39篇 |
1978年 | 38篇 |
1977年 | 25篇 |
1976年 | 21篇 |
1975年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Eriketi Z. Loizidou Constantinos D. Zeinalipour‐Yazdi 《Chemical biology & drug design》2014,84(1):99-107
A computational procedure was developed to study the subunit‐specific interactions of the proteasome inhibitors argyrin A and F, with the aim of indentifying the determinants of subunit selectivity. Three‐dimensional models of humanized proteasome active sites β1, β2 and β5 were developed and subsequently used in molecular docking simulations with the argyrin analogues. The subunit selectivity exhibited by each analogue could be explained based on the site‐specific interactions and a probability‐based specificity parameter derived in this study. A rational approach that involved maximizing site‐specific interactions was followed to guide the design of new argyrin analogues as specific inhibitors of the caspase‐like (β1 site) activity. 相似文献
992.
Elisabeth Favre Antoine Daina Pierre‐Alain Carrupt Alessandra Nurisso 《Chemical biology & drug design》2014,84(2):206-215
Tyrosinases are type 3 copper proteins involved in melanin biosynthesis, responsible for skin and hair color in mammals. To steer tyrosinase inhibitor discovery for therapeutic and cosmetic purposes, structural information about human tyrosinase is necessary. As this protein has never been crystallized so far, we derived a robust homology model built using structural information from Streptomyces castaneoglobisporus and Ipomea batata catecholoxidase enzymes. The active site containing two copper atoms in co‐ordination with six histidine residues was refined through an optimization protocol based on molecular mechanics parameters for copper co‐ordination and charges calculated by quantum mechanics methods. Five structural water molecules and a hydroxyl ion were found to be essential for optimization. The superimposition of the human homology model on crystallographic structures of tyrosinases from other species revealed similar overall backbone topologies, active site conformations, and conserved water molecules. Phenylthiourea (PTU), the tyrosinase inhibitor of reference, was then docked into the solvated human active pocket. A binding mode consistent with crystallographic information was obtained. Taken together, these findings demonstrated that the human tyrosinase model, deposited in the Protein Model Database, is a reliable structure for future rational inhibitor design projects. 相似文献
993.
Yan Li Chunxiao Han Jinghui Wang Yinfeng Yang Jingxiao Zhang Shuwei Zhang Ling Yang 《Chemical biology & drug design》2014,83(6):643-655
Presently, both ligand‐based and receptor‐based 3D‐QSAR modelings were performed on 107 pyrazolopyrimidine‐ and pyrazolopyridine‐based inhibitors of B‐RafV600E kinase. The optimal model is successful to predict the inhibitors' activity with Q2 of 0.504, R2ncv of 0.960, and R2pred of 0.872. Besides, the 3D contour maps explain well the structural requirements of the interaction between the ligand and the receptor. Furthermore, molecular docking and MD were also carried out to study the binding mode. Our findings are the following: (i) Bulky substituents at position 3, 10 and ring D improve the inhibitory activity, but impair the activity at position 5, 11, and 19. (ii) Electropositive groups at position 10, 13 and 20 and electronegative groups at position 2 increase the biological activity. (iii) Hydrophobic substituents at ring C are beneficial to improve the biological activity, while hydrophilic substituents at position 11 and ring D are good for the activity. (4) This scaffold of inhibitors may bind to the B‐Raf kinase with an ‘L’ conformation and belong to type III binding mode, which is fixed by hydrophobic interaction and hydrogen bonds with residues from hinge region and DFG motif. These results may be a guidance to develop new B‐RafV600E kinase inhibitors. 相似文献
994.
995.
Jiansong Fang Ping Wu Ranyao Yang Li Gao Chao Li Dongmei Wang Song Wu Ai-Lin Liu Guan-Hua Du 《药学学报(英文版)》2014,4(6):430-437
In this study two genistein derivatives (G1 and G2) are reported as inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), and differences in the inhibition of AChE are described. Although they differ in structure by a single methyl group, the inhibitory effect of G1 (IC50=264 nmol/L) on AChE was 80 times stronger than that of G2 (IC50=21,210 nmol/L). Enzyme-kinetic analysis, molecular docking and molecular dynamics (MD) simulations were conducted to better understand the molecular basis for this difference. The results obtained by kinetic analysis demonstrated that G1 can interact with both the catalytic active site and peripheral anionic site of AChE. The predicted binding free energies of two complexes calculated by the molecular mechanics/generalized born surface area (MM/GBSA) method were consistent with the experimental data. The analysis of the individual energy terms suggested that a difference between the net electrostatic contributions (ΔEele+ΔGGB) was responsible for the binding affinities of these two inhibitors. Additionally, analysis of the molecular mechanics and MM/GBSA free energy decomposition revealed that the difference between G1 and G2 originated from interactions with Tyr124, Glu292, Val294 and Phe338 of AChE. In conclusion, the results reveal significant differences at the molecular level in the mechanism of inhibition of AChE by these structurally related compounds.KEY WORDS: Genistein derivatives, Acetylcholinesterase (AChE), Kinetics analysis, Molecular docking, Molecular dynamics simulation, MM/GBSAAbbreviations: ACh, acetylcholine; AChEIs, acetylcholinesterase inhibitors; AChE, acetylcholinesterase; AD, Alzheimer׳s disease; BuChE, butyrylcholinesterase; BuSCh, S-butyrylthiocholine chloride; CAS, catalytic active site; DTNB, 5,5′-dithiobis-(2-nitrobenzoic acid); GAFF, generalized AMBER force field; G1, 3-(4-methoxyphenyl)-7-(2-(piperidin-1-yl)ethoxy)-4H-chromen-4-one; G2, (S)-3-(4-methoxyphenyl)-7-(2-(2-methylpiperidin-1-yl)ethoxy)-4H-chromen-4-one; iso-OMPA, tetraisopropyl pyrophosphoramide; MD, molecular dynamics; MM/GBSA, molecular mechanics/generalized born surface area; PAS, peripheral anionic site; PDB, protein data bank; PME, particle mesh Ewald; RMSD, root-mean-square deviation; S-ACh, acetylthiocholine iodide; ΔEele, electrostatic energy contribution; ΔEMM, gas-phase interaction energy between receptor and ligand; ΔEvdw, van der Waals energy contribution; SASA, solvent accessible surface area; ΔGexp, experimental binding free energy; ΔGGB, polar desolvation energy term; ΔGpred, total binding free energy; ΔGSA, nonpolar desolvation energy term; ΔS, conformational entropy contribution 相似文献
996.
目的:探讨单独使用免疫检查点阻断剂(immune checkpoint inhibitors,ICI)、ICI与靶向抗血管生成的酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)联合使用两种情况下,免疫反应介导性肝炎(immune-mediated hepatitis,IMH)的组织学表现差异。方法:收集2015至2019年在复旦大学附属中山医院接受抗ICI治疗发生肝功能异常且获得肝组织标本的病例21例。其中10例使用单药ICI,另11例使用ICI及靶向抗血管TKI联合治疗,观察组织病理形态,使用免疫组织化学方法检测程序性死亡配体1、2(programmed cell death-ligand 1,PD-L1/2)表达情况。结果:单药ICI治疗的IMH表现为程度不等、均匀分布于肝小叶及汇管区的炎性病变,并可出现小胆管炎、静脉内皮炎、Kupffer细胞活化及紫癜样变。8例(8/10)出现轻度肝损伤,2例(2/10)出现轻-中度肝损伤。在使用ICI及抗血管TKI联合治疗的患者中,肝损伤往往较为严重,其中4例(4/11)出现中-重度肝损伤,肝细胞桥接坏死、大片坏死,汇管区中-重度炎性病变,部分小胆管上皮变性,伴显著界面性肝炎。在较严重IMH的病例中,较多CD8+的T淋巴细胞聚集在汇管区及肝窦内,且有部分肝窦内皮细胞表达PD-L1。单药治疗、联合治疗中各有2例发生死亡,其中联合治疗组中有1例发生急性多发性肝炎,肝组织大片凝固性坏死,肝功能不可逆损伤,最终患者因多系统免疫失调,多器官衰竭而死亡。结论:与单用ICI相比,联合使用ICI及抗血管TKI有可能造成肝细胞的叠加损伤,引起严重IMH的可能性更高。 相似文献
997.
Xiangyu Teng Josephine Brown Seung-Chul Choi Wei Li Laurence Morel 《Immunological reviews》2020,295(1):167-186
The metabolism of healthy murine and more recently human immune cells has been investigated with an increasing amount of details. These studies have revealed the challenges presented by immune cells to respond rapidly to a wide variety of triggers by adjusting the amount, type, and utilization of the nutrients they import. A concept has emerged that cellular metabolic programs regulate the size of the immune response and the plasticity of its effector functions. This has generated a lot of enthusiasm with the prediction that cellular metabolism could be manipulated to either enhance or limit an immune response. In support of this hypothesis, studies in animal models as well as human subjects have shown that the dysregulation of the immune system in autoimmune diseases is associated with a skewing of the immunometabolic programs. These studies have been mostly conducted on autoimmune CD4+ T cells, with the metabolism of other immune cells in autoimmune settings still being understudied. Here we discuss systemic metabolism as well as cellular immunometabolism as novel tools to decipher fundamental mechanisms of autoimmunity. We review the contribution of each major metabolic pathway to autoimmune diseases, with a focus on systemic lupus erythematosus (SLE), with the relevant translational opportunities, existing or predicted from results obtained with healthy immune cells. Finally, we review how targeting metabolic programs may present novel therapeutic venues. 相似文献
998.
Damage accumulation in long-living macromolecules (especially extracellular matrix (ECM) proteins, nuclear pore complex (NPC) proteins, and histones) is a missing hallmark of aging. Stochastic non-enzymatic modifications of ECM trigger cellular senescence as well as many other hallmarks of aging affect organ barriers integrity and drive tissue fibrosis. The importance of it for aging makes it a key target for interventions. The most promising of them can be AGE inhibitors (chelators, O-acetyl group or transglycating activity compounds, amadorins and amadoriases), glucosepane breakers, stimulators of elastogenesis, and RAGE antagonists. 相似文献
999.
1000.
Avinash Kumar Ekta Rathi Raghu Chandrashekar Hariharapura Suvarna G. Kini 《Medicinal research reviews》2020,40(5):2019-2048
An understanding of the pathology of cervical cancer (CC) mediated by E6/E7 oncoproteins of high-risk human papillomavirus (HPV) was developed by late 80's. But if we look at the present scenario, not a single drug could be developed to inhibit these oncoproteins and in turn, be used specifically for the treatment of CC. The readers are advised not to presume the “viability of E6 protein” as mentioned in the title relates to just druggability of E6. The viability aspect will cover almost everything a researcher should know to develop E6 inhibitors until the preclinical stage. Herein, we have analysed the achievements and shortcomings of the scientific community in the last four decades in targeting HPV E6 against CC. Role of all HPV proteins has been briefly described for better perspective with a little detailed discussion of the role of E6. We have reviewed the articles from 1985 onward, reporting in vitro inhibition of E6. Recently, many computational studies have reported potent E6 inhibitors and these have also been reviewed. Subsequently, a critical analysis has been reported to cover the in vitro assay protocols and in vivo models to develop E6 inhibitors. A paragraph has been devoted to the role of public policy to fight CC employing vaccines and whether the vaccine against HPV has quenched the zeal to develop drugs against it. The review concludes with the challenges and the way forward. 相似文献